Abstract
Delayed puberty is defined as the absence of any sign of puberty in a child at a chronologic age 2 standard deviations above the mean age of pubertal development for a given population. Normal puberty is initiated by the onset of pulsatile secretion of gonadotropin-releasing hormone (GnRH) from the hypothalamus. These pulses cause release of luteinizing hormone (LH) and follicular-stimulating hormone (FSH) from the pituitary gland. These pituitary gonadotropins then circulate to the gonads and stimulate production of sex steroids. The differential diagnosis of pubertal delay is extensive but can most easily be divided into three categories: The first group represents temporary delays of puberty that are functional disorders, most commonly, constitutional delay of growth and puberty. The second is hypogonadotropic hypogonadism, in which hypothalamic or pituitary failure results in deficiency of circulating gonadotropins. Finally, hypergonadotropic hypogonadism results from primary gonadal failure, with subsequent lack of negative feedback of sex steroids at the hypothalamic and pituitary levels resulting in elevated serum gonadotropin levels.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in girls. Am J Dis Child. 1969;44:291–301.
Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Am J Dis Child. 1970;45:13–21.
Argente J. Diagnosis of late puberty. Horm Res. 1999;51 Suppl 3:95–100.
Sedelmeyer I, Palmert MR. Delayed puberty: analysis of a large case series from an academic center. J Clin Endocrinol Metab. 2002;87(4):1613–20.
Rosenfield RL. Clinical Review 6: diagnosis and management of delayed puberty. J Clin Endocrinol Metab. 1990;70(3):559–62.
Warren PW. Effects of undernutrition on reproductive function in the human. Endocr Rev. 1983;4:363–77.
Warren MP, Van de Wiele RL. Clinical and metabolic features of anorexia nervosa. Am J Obstet Gynecol. 1973;117:435–49.
Hudson JL, Hudson MS. Endocrine dysfunction in anorexia nervosa and bulimia: comparison with abnormalities in other psychiatric disorders and disturbances due to metabolic factors. Psychiatr Dev. 1984;2(4):237–72.
Weimann E, Witzel C, Schwidergall S, Bohles HJ. Prepubertal perturbations in elite gymnasts caused by sport specific training regimens and inadequate nutritional intake. Int J Sports Med. 2000;21(3):210–5.
Warren MP, Stiehl AL. Exercise and female adolescents: effects on the reproductive and skeletal systems. J Am Med Womens Assoc. 1999;54(3):115–20.
Picardi A, Cipponeri E, Bizzarri C, Fallucca S, Guglielmi C, Possilli P. Menarche in type 1 diabetes is still delayed despite good metabolic control. Fertil Steril. 2008;90(5):1875–7.
Pallais JC, Au M, Pitteloud N, Seminara S, Crowley Jr W. Isolated gonadotropin-releasing hormone (GnRH) deficiency overview. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2007. May 23 [updated 2010 Oct 14].
Dwyer AA, Hayes FJ, Plummer L, Pitteloud N, Crowley Jr WF. The long-term clinical follow-up and natural history of men with adult-onset idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2010;95(9):4235–43.
Herbison A. Genetics of puberty. Horm Res. 2007;68 Suppl 5:75–9.
Pallais JC, Au M, Pitteloud N, Seminara S, Crowley Jr W. Kallmann syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2007. May 23 [updated 2011 Jan 04].
Layman LC. The molecular basis of human hypogonadotropic hypogonadism. Mol Genet Metab. 1999;68:191–9.
Silveria L, Trarback E, Latronico AC. Genetic basis for GnRH-dependent pubertal disorders in humans. Mol Cell Endocrinol. 2010;324:30–8.
Chan Y, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaris S, Gaspert A, Lavoie HB, Wu C-H, Crowley Jr WF, Amory JK, Pitteloud N, Seminara S. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci U S A. 2009;106(28):11703–8.
Niakan LL, McCabe ER. DAX-1 origin, function and novel role. Mol Genet Metab. 2005;86(1–2):70–83.
Merke DP, Tajima T, Baron J, Cutler GB. Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. N Engl J Med. 1999;340:1248–52.
Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley Jr W, Jameson JL. Hypogonadism caused by a single amino acid substitution in the β subunit of luteinizing hormone. N Engl J Med. 1992;326:179–83.
Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambin G, Casagrande S, Tedeschini G, Benedetti A, Chaterjee VKK. Primary amenorrhea and infertility due to mutation in the β-subunit of follicle-stimulating hormone. Nat Genet. 1993;5:83–6.
Layman LC, Lee EJ, Peak DB, Namnoum AB, Vu KK, van Lingen BL, Gray MR, McDonough PG, Reindollar RH, Jameson JL. Delayed puberty and hypogonadism caused by a mutation in the follicle stimulating hormone beta-subunit gene. N Engl J Med. 1997;337:607–11.
Cogan JD, Wu W, Phillips JAI, Arnhold IJP, Agapito A, Fofanova OV, Osorio MGF, Bircan I, Moreno A, Mendonca BB. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab. 1998;83:3346–9.
Wu W, Cogan JD, Pfaffle RW, Dasen JS, Frisch H, O’Connell SM, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips III JA, Rosenfeld MG. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet. 1998;18:147–9.
Kelberman D, Dattani MT. Role of transcription factors in midline central nervous system and pituitary defects. Endocr Dev. 2009;14:67–82.
Dauber A, Hirschhorn JN, Picker J, Maher TA, Milunsky A. Delayed puberty due to a novel mutation in CHD7 causing CHARGE. Pediatrics. 2010;126(6):e1594–8.
Rappaport R, Brauner R. Growth and endocrine disorders secondary to cranial irradiation. Pediatr Res. 1989;25(6):561–7.
Smyth CM, Bremner WJ. Klinefelter syndrome. Arch Intern Med. 1998;158(12):1309–14.
Laue L, Wu SM, Kudo M, et al. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. Hum Mol Genet. 1995;4:1429–33.
Kremer H, Kraaij R, Toledo SP, et al. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nat Genet. 1995;9:160–4.
Latronico AC, Anasti J, Arnhold IJP, et al. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N Engl J Med. 1996;334:507–12.
Gromoll J, Eiholzer U, Nieschlag E, Simoni M. Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH. J Clin Endocrinol Metab. 2000;85(6):2281–6.
Jamieson CR, van der Burgt I, Brady AF, van Reen M, Elsawi MM, Hol F, Jeffrey S, Patton MA, Mariman E. Mapping a gene for Noonan syndrome to the long arm of chromosome 12. Nat Genet. 1994;8:357–60.
Romano AA, Allanson JE, Dahlgren J, Gelb BD, Hall B, Pierpont ME, Roberts AE, Robinson W, Takemoto CM, Noonan JA. Noonan syndrome: clinical features, diagnosis, and management guidelines. Pediatrics. 2010;126(4):746–59.
Blagovidow N, Page DC, Huff DE, et al. Ullrich Turner syndrome in a XY female fetus with deletion of the sex-determining portion of the Y chromosome. Am J Med Genet. 1989;34:159–62.
Scherer G, Chempp W, Baccichetti C, et al. Duplication of an Xp segment that includes the ZFX locus causes sex inversion in man. Hum Genet. 1989;81:291–4.
Aittomaki K, Herva R, Stenman U-H, Juntunen K, Ylostalo P, Hovatta O, de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J Clin Endocrinol Metab. 1996;81:3722–6.
Rappaport R, Maguelone GF. Disorders of sexual differentiation. In: Bertrand J, Rappaport R, Sizonenko P, editors. Pediatric endocrinology: physiology, pathophysiology, and clinical aspects. 2nd ed. London: Williams and Wilkins; 1993.
New MI. Inborn errors of adrenal steroidogenesis. Mol Cell Endocrinol. 2003;211(1–2):75–83.
Brinkmann AO. Molecular basis of androgen insensitivity. Mol Cell Endocrinol. 2001;179(1–2):105–9.
McPhaul MJ. Molecular defects of the androgen receptor. J Steroid Biochem Mol Biol. 1999;69(1–6):315–22.
Evans BAJ, Hughes IA, Bevan CL, Patterson MN, Gregory JW. Phenotypic diversity in siblings with partial androgen insensitivity syndrome. Arch Dis Child. 1997;76:529–31.
Bramswig JH, Heimes U, Heiermann E, et al. The effects of different cumulative doses of chemotherapy on testicular function. Cancer. 1990;65:1298–302.
Sanders JE. Growth and development after hematopoietic cell transplant in children. Bone Marrow Transplant. 2008;41(2):223–7.
Bayer L, Bayley N. Growth diagnosis. Chicago: University of Chicago Press; 1959.
Reynolds EL, Wines JV. Physical changes associated with adolescence in boys. Am J Dis Child. 1951;82:529–47.
Harlan W, Grillo G, Cornoni-Huntley J, Leaverton P. Sexual characteristics of boys 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr. 1979;95(2):293–7.
Harlan W, Harlan E, Grillo G. Sexual characteristics of girls 12 to 17 years of age: the U.S. Health Examination Survey. J Pediatr. 1980;96(6):1074–8.
Odink RJ, Schoemaker J, Schoute E, Herder E, Delemarre-van de Waal HA. Predictive value of serum follicular-stimulating hormone levels in the differentiation between hypogonadotropic hypogonadism and constitutional delay of puberty. Horm Res. 1998;49(6):279–87.
Grinspon RP, Ropelato MG, Gottlieb S, Keselman A, Martínez A, Ballerini MG, Domené HM, Rey RA. Basal follicle-stimulating hormone and peak gonadotropin levels after gonadotropin-releasing hormone infusion show high diagnostic accuracy in boys with suspicion of hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2010;95(6):2811–8.
Wu FCW, Brown DC, Butler GE, Stirling HF, Kelnar CJH. Early morning plasma testosterone is an accurate predictor of imminent pubertal development in prepubertal boys. J Clin Endocrinol Metab. 1990;70:26–31.
Gambineri A, Pasquali R. Testosterone therapy in men: clinical and pharmacological perspectives. J Endocrinol Invest. 2000;23:196–214.
Brook CGD. Treatment of late puberty. Horm Res. 1999;51 suppl 3:101–3.
Richmond EJ, Rogol AD. Male pubertal development and the role of androgen therapy. Nat Clin Pract Endocrinol Metab. 2007;3:338–44.
Bourguignon J-P. Delayed puberty and hypogonadism. In: Bertrand J, Rappaport R, Sizonenko P, editors. Pediatric endocrinology: physiology, pathophysiology, and clinical aspects. 2nd ed. London: Williams and Wilkins; 1993.
Pozo J, Argente J. Ascertainment and treatment of delayed puberty. Horm Res. 2003;60 suppl 3:35–48.
Mayo A, Macintyre H, Wallace AM, Ahmed SF. Transdermal testosterone application: pharmacokinetics and effects on pubertal status, short-term growth, and bone turnover. J Clin Endocrinol Metab. 2004;89(2):681–7.
De Sanctis V, Vullo C, Urso L, Rigolin F, Cavallini A, Caramelli K, Daugherty C, Mazer N. Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major. J Pediatr Endocrinol Metab. 1998;11 Suppl 3:891–900.
Divasta AD, Gordon CM. Hormone replacement therapy and the adolescent. Curr Opin Obstet Gynecol. 2010;22:363–8.
Finkelstein JW, Susman EJ, Chinchilli VM, et al. Effects of estrogen or testosterone on self-reported sexual responses and behaviors in hypogonadal adolescents. J Clin Endocrinol Metab. 1998;83(7):2281–5.
Susman EF, Finkelstein JW, Chinchilli VM, et al. The effect of sex hormone replacement therapy on behavior problems and moods in adolescents with delayed puberty. J Pediatr. 1998;133(4):521–5.
Hoffman AR, Crowley WF. Induction of puberty in men by long-term pulsatile administration of low dose gonadotropin-releasing hormone. N Engl J Med. 1982;307:1237–41.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Stafford, D.E.J. (2013). Turner Syndrome, Kallmann Syndrome and Noonan Syndrome. In: Radovick, S., MacGillivray, M. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-395-4_22
Download citation
DOI: https://doi.org/10.1007/978-1-60761-395-4_22
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-394-7
Online ISBN: 978-1-60761-395-4
eBook Packages: MedicineMedicine (R0)